Injection: Hypersensitivity: The administration should be discontinued if signs and symptoms of hypersensitivities appear.
Dermatological: Pruritus or eruption may rarely occur.
Ocular: Disturbance of color vision, although rarely, may occur following IV administration of Hemotrex.
Shock: Hemotrex may, although rarely, cause shock. Therefore, the patients should be carefully observed during therapy. If any symptoms occur, the administration should be discontinued and appropriate therapy should be instituted.
Others: Drowsiness or headache may rarely occur.
View ADR Monitoring Form